SECTOR GAMMA AS
Filing Date
Global Rank
#4,044
/ 8,798
▼ 419
· as of Jun 2026
Top Industry
Drug Manufacturers - General
25.8%
Period ended 3 months ago
Filed Aug 12, 2026 · 59d
26 quarters · since Mar 2020
Clone Performance
Build a hypothetical price-return history from this filer's public 13F holdings.
View clone backtestPortfolio Concentration
40 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026Top Position
9.1%
−2.8 pts
Top 5
30.6%
−6.1 pts
Top 10
48.4%
−5.7 pts
HHI
370
Diversified−73
Portfolio Trend
26 quarters · across all stocks
Sector Breakdown
As of Jun 30, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $460,970,491 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
19 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| AVTR | Avantor, Inc. | +210,685 | 906,088 | $8,970,271 | |
| ARDX | Ardelyx, Inc. | +170,713 | 686,844 | $3,502,904 | |
| QGEN | Qiagen N.V. | +125,269 | 287,640 | $11,246,724 | |
| GEHC | GE HealthCare Technologies Inc. | +81,445 | 207,863 | $13,305,310 | |
| MDT | Medtronic plc | +71,755 | 352,437 | $27,571,146 | |
| IOVA | Iovance Biotherapeutics, Inc. | +68,466 | 968,466 | $4,028,818 | |
| ABT | Abbott Laboratories | +59,912 | 147,444 | $13,379,068 | |
| BMRN | Biomarin Pharmaceutical Inc | +55,000 | 294,918 | $16,875,207 | |
| DXCM | Dexcom Inc | +46,000 | 102,122 | $6,877,916 | |
| IQV | Iqvia Holdings Inc. | +37,714 | 77,944 | $15,060,339 | |
| PTCT | Ptc Therapeutics, Inc. | +25,000 | 100,000 | $8,157,000 | |
| KURA | Kura Oncology, Inc. | +21,202 | 433,012 | $4,750,141 | |
| — | +20,433 | 114,628 | $4,289,379 | ||
| CVS | CVS HEALTH Corp | +20,000 | 155,337 | $16,069,612 | |
| IONS | Ionis Pharmaceuticals Inc | +20,000 | 189,468 | $15,022,917 | |
| BDX | Becton Dickinson & Co | +10,553 | 93,168 | $14,099,113 | |
| BIO | Bio-Rad Laboratories, Inc. | +9,600 | 33,350 | $9,791,893 | |
| LH | Labcorp Holdings Inc. | +7,000 | 26,019 | $7,285,320 | |
| ELV | Elevance Health, Inc. | +537 | 44,499 | $17,209,098 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
11 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| OGN | Organon & Co. | −105,193 | 270,781 | $3,666,374 | |
| BMY | Bristol Myers Squibb Co | −101,786 | 726,115 | $41,838,746 | |
| BRKR | Bruker Corp | −101,658 | 152,352 | $9,168,543 | |
| PFE | Pfizer Inc | −87,170 | 1,004,215 | $24,181,497 | |
| SNDX | Syndax Pharmaceuticals Inc | −44,268 | 241,739 | $5,284,414 | |
| MRK | Merck & Co., Inc. | −43,332 | 217,008 | $27,885,528 | |
| BIIB | Biogen Inc. | −35,933 | 54,163 | $11,702,457 | |
| INCY | Incyte Corp | −29,757 | 170,753 | $19,356,560 | |
| AMGN | Amgen Inc | −20,874 | 26,281 | $9,516,875 | |
| CAH | Cardinal Health Inc | −14,208 | 40,689 | $9,666,078 | |
| ZBH | Zimmer Biomet Holdings, Inc. | −13,528 | 142,307 | $12,251,209 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
6 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| TMO | Thermo Fisher Scientific Inc. | 33,584 | $16,837,674 | |
| REGN | Regeneron Pharmaceuticals, Inc. | 15,780 | $9,839,461 | |
| BSX | Boston Scientific Corp | 121,128 | $5,169,743 | |
| TVTX | Travere Therapeutics, Inc. | 80,000 | $4,544,800 | |
| CYTK | Cytokinetics Inc | 45,000 | $3,833,550 | |
| NTLA | Intellia Therapeutics, Inc. | 185,177 | $3,133,194 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
8 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| UNH | Unitedhealth Group Inc | 36,435 | $9,858,946 | |
| GILD | Gilead Sciences, Inc. | 53,247 | $7,421,034 | |
| LNTH | Lantheus Holdings, Inc. | 93,344 | $7,080,142 | |
| HUM | Humana Inc | 19,202 | $3,329,434 | |
| BBIO | BridgeBio Pharma, Inc. | 44,263 | $3,286,970 | |
| DNLI | Denali Therapeutics Inc. | 162,710 | $3,124,032 | |
| COGT | Cogent Biosciences, Inc. | 80,000 | $3,079,200 | |
| ARWR | Arrowhead Pharmaceuticals, Inc. | 30,000 | $1,881,000 | |
| No positions match the current search. | ||||
40 tracked positions ·
$460,970,491 total
· filing declares
40 positions · $460,970,513
· as of Jun 30, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| BMY |
Bristol Myers Squibb Co
Healthcare
|
Reduced | 726,115 | $41,838,746 | 9.08% | |
| MRK |
Merck & Co., Inc.
Healthcare
|
Reduced | 217,008 | $27,885,528 | 6.05% | |
| MDT |
Medtronic plc
Healthcare
|
Added | 352,437 | $27,571,146 | 5.98% | |
| PFE |
Pfizer Inc
Healthcare
|
Reduced | 1,004,215 | $24,181,497 | 5.25% | |
| INCY |
Incyte Corp
Healthcare
|
Reduced | 170,753 | $19,356,560 | 4.20% | |
| ELV |
Elevance Health, Inc.
Healthcare
|
Added | 44,499 | $17,209,098 | 3.73% | |
| BMRN |
Biomarin Pharmaceutical Inc
Healthcare
|
Added | 294,918 | $16,875,207 | 3.66% | |
| TMO |
Thermo Fisher Scientific Inc.
Healthcare
|
NEW | 33,584 | $16,837,674 | 3.65% | |
| CVS |
CVS HEALTH Corp
Healthcare
|
Added | 155,337 | $16,069,612 | 3.49% | |
| IQV |
Iqvia Holdings Inc.
Healthcare
|
Added | 77,944 | $15,060,339 | 3.27% | |
| IONS |
Ionis Pharmaceuticals Inc
Healthcare
|
Added | 189,468 | $15,022,917 | 3.26% | |
| BDX |
Becton Dickinson & Co
Healthcare
|
Added | 93,168 | $14,099,113 | 3.06% | |
| ABT |
Abbott Laboratories
Healthcare
|
Added | 147,444 | $13,379,068 | 2.90% | |
| GEHC |
GE HealthCare Technologies Inc.
Healthcare
|
Added | 207,863 | $13,305,310 | 2.89% | |
| ZBH |
Zimmer Biomet Holdings, Inc.
Healthcare
|
Reduced | 142,307 | $12,251,209 | 2.66% | |
| BIIB |
Biogen Inc.
Healthcare
|
Reduced | 54,163 | $11,702,457 | 2.54% | |
| QGEN |
Qiagen N.V.
Healthcare
|
Added | 287,640 | $11,246,724 | 2.44% | |
| CNC |
Centene Corp
Healthcare
|
Held | 162,405 | $10,424,776 | 2.26% | |
| REGN |
Regeneron Pharmaceuticals, Inc.
Healthcare
|
NEW | 15,780 | $9,839,461 | 2.13% | |
| BIO |
Bio-Rad Laboratories, Inc.
Healthcare
|
Added | 33,350 | $9,791,893 | 2.12% | |
| CAH |
Cardinal Health Inc
Healthcare
|
Reduced | 40,689 | $9,666,078 | 2.10% | |
| AMGN |
Amgen Inc
Healthcare
|
Reduced | 26,281 | $9,516,875 | 2.06% | |
| BRKR |
Bruker Corp
Healthcare
|
Reduced | 152,352 | $9,168,543 | 1.99% | |
| AVTR |
Avantor, Inc.
Healthcare
|
Added | 906,088 | $8,970,271 | 1.95% | |
| PTCT |
Ptc Therapeutics, Inc.
Healthcare
|
Added | 100,000 | $8,157,000 | 1.77% | |
| LH |
Labcorp Holdings Inc.
Healthcare
|
Added | 26,019 | $7,285,320 | 1.58% | |
| DXCM |
Dexcom Inc
Healthcare
|
Added | 102,122 | $6,877,916 | 1.49% | |
| ASND |
Ascendis Pharma A/S
Healthcare
|
Held | 21,305 | $5,682,469 | 1.23% | |
| EW |
Edwards Lifesciences Corp
Healthcare
|
Held | 60,402 | $5,463,964 | 1.19% | |
| SNDX |
Syndax Pharmaceuticals Inc
Healthcare
|
Reduced | 241,739 | $5,284,414 | 1.15% | |
| BSX |
Boston Scientific Corp
Healthcare
|
NEW | 121,128 | $5,169,743 | 1.12% | |
| KURA |
Kura Oncology, Inc.
Healthcare
|
Added | 433,012 | $4,750,141 | 1.03% | |
| TVTX |
Travere Therapeutics, Inc.
Healthcare
|
NEW | 80,000 | $4,544,800 | 0.99% | |
|
|
Added | 114,628 | $4,289,379 | 0.93% | ||
| TNDM |
Tandem Diabetes Care Inc
Healthcare
|
Held | 267,091 | $4,030,403 | 0.87% | |
| IOVA |
Iovance Biotherapeutics, Inc.
Healthcare
|
Added | 968,466 | $4,028,818 | 0.87% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
NEW | 45,000 | $3,833,550 | 0.83% | |
| OGN |
Organon & Co.
Healthcare
|
Reduced | 270,781 | $3,666,374 | 0.80% | |
| ARDX |
Ardelyx, Inc.
Healthcare
|
Added | 686,844 | $3,502,904 | 0.76% | |
| NTLA |
Intellia Therapeutics, Inc.
Healthcare
|
NEW | 185,177 | $3,133,194 | 0.68% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.